CLNN
Price
$3.31
Change
-$0.09 (-2.65%)
Updated
Jul 29, 01:07 PM (EDT)
Capitalization
30.54M
ELAB
Price
$2.25
Change
-$0.02 (-0.88%)
Updated
Jul 29, 01:31 PM (EDT)
Capitalization
3.12M
Interact to see
Advertisement

CLNN vs ELAB

Header iconCLNN vs ELAB Comparison
Open Charts CLNN vs ELABBanner chart's image
Clene
Price$3.31
Change-$0.09 (-2.65%)
Volume$755
Capitalization30.54M
PMGC Holdings
Price$2.25
Change-$0.02 (-0.88%)
Volume$200
Capitalization3.12M
CLNN vs ELAB Comparison Chart in %
Loading...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLNN vs. ELAB commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLNN is a StrongBuy and ELAB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (CLNN: $3.40 vs. ELAB: $2.27)
Brand notoriety: CLNN and ELAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLNN: 71% vs. ELAB: 2%
Market capitalization -- CLNN: $30.54M vs. ELAB: $3.12M
CLNN [@Biotechnology] is valued at $30.54M. ELAB’s [@Biotechnology] market capitalization is $3.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLNN’s FA Score shows that 0 FA rating(s) are green whileELAB’s FA Score has 1 green FA rating(s).

  • CLNN’s FA Score: 0 green, 5 red.
  • ELAB’s FA Score: 1 green, 4 red.
According to our system of comparison, ELAB is a better buy in the long-term than CLNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLNN’s TA Score shows that 4 TA indicator(s) are bullish while ELAB’s TA Score has 4 bullish TA indicator(s).

  • CLNN’s TA Score: 4 bullish, 5 bearish.
  • ELAB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ELAB is a better buy in the short-term than CLNN.

Price Growth

CLNN (@Biotechnology) experienced а -12.14% price change this week, while ELAB (@Biotechnology) price change was -5.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.72%. For the same industry, the average monthly price growth was +19.99%, and the average quarterly price growth was +45.42%.

Industries' Descriptions

@Biotechnology (+6.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLNN($30.5M) has a higher market cap than ELAB($3.12M). CLNN YTD gains are higher at: -35.970 vs. ELAB (-85.839). ELAB has higher annual earnings (EBITDA): -4.33M vs. CLNN (-24.01M). CLNN has more cash in the bank: 9.83M vs. ELAB (5.92M). ELAB has less debt than CLNN: ELAB (103K) vs CLNN (20.9M). CLNN has higher revenues than ELAB: CLNN (350K) vs ELAB (0).
CLNNELABCLNN / ELAB
Capitalization30.5M3.12M977%
EBITDA-24.01M-4.33M554%
Gain YTD-35.970-85.83942%
P/E RatioN/AN/A-
Revenue350K0-
Total Cash9.83M5.92M166%
Total Debt20.9M103K20,291%
FUNDAMENTALS RATINGS
CLNN: Fundamental Ratings
CLNN
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
23

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLNNELAB
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 9 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COF214.182.85
+1.35%
Capital One Financial
PRQR2.240.01
+0.45%
ProQR Therapeutics NV
BIPC41.52-0.21
-0.50%
Brookfield Infrastructure Corp
PRM16.53-0.33
-1.96%
Perimeter Solutions Inc
GTEC1.73-0.06
-3.35%
Greenland Technologies Holding Corp

CLNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLNN has been closely correlated with RIGL. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CLNN jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLNN
1D Price
Change %
CLNN100%
-6.85%
RIGL - CLNN
92%
Closely correlated
-0.89%
DARE - CLNN
88%
Closely correlated
-1.54%
HOOK - CLNN
86%
Closely correlated
+0.87%
PHIO - CLNN
83%
Closely correlated
-7.66%
IMRN - CLNN
80%
Closely correlated
-2.91%
More

ELAB and

Correlation & Price change

A.I.dvisor tells us that ELAB and EPIX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAB and EPIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
-0.44%
EPIX - ELAB
32%
Poorly correlated
-0.53%
LXRX - ELAB
21%
Poorly correlated
-0.91%
CLNN - ELAB
21%
Poorly correlated
-6.85%
ASMB - ELAB
20%
Poorly correlated
+5.12%
MTNB - ELAB
20%
Poorly correlated
-0.01%
More